کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
599116 | 1454264 | 2016 | 9 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium](/preview/png/599116.png)
• Physically stable dasatinib-loaded PEG-b-PLC nanomicelles were prepared with an enhanced solubility.
• Both blank and dasatinib-loaded polymeric micelles were non-cytotoxic towards ARPE-19 cells.
• Dasatinib-loaded micelles significantly inhibited PVR-related cellular changes of the retinal pigment epithelium compared to the free drug, the concentration of which was limited due to its poor solubility.
• There is a linear correlation between cellular uptake and the anti-proliferating effect of polymeric micelles.
• Drug loading appears to be a critical parameter for cellular uptake which in turn impacts the in vitro bioactivities of polymeric micelles.
The objective of this study was to fabricate dasatinib-loaded nanoparticles and evaluate their efficacy in inhibiting cellular processes of the retinal pigment epithelium (RPE) related to proliferative vitreoretinopathy (PVR), for which there are no approved pharmacological approaches. We successfully encapsulated dasatinib, a poorly soluble multi-targeted tyrosine kinase inhibitor which has great potential for the treatment of PVR, into nanoparticles prepared from micellation of PEG-b-PCL. The size of the nanomicelles was approximately 55 nm with a narrow distribution. They increased the solubility of dasatinib by 475× and provided a sustained drug release. ARPE-19, an immortal RPE cell line, was used to assess the in vitro efficacy of micellar dasatinib because the RPE is believed to play a key role in the pathogenesis of PVR. Three cell-based assays, namely, proliferation, adhesion and migration, which represent three important PVR-related cellular changes of the RPE, were conducted and the cytotoxicity of micelles was also evaluated. Both blank and dasatinib-loaded micelles were non-cytotoxic towards ARPE-19 cells. Micellar dasatinib significantly inhibited cell proliferation, adhesion and migration compared to the free drug; this might be attributable to enhanced solubility. PEG-b-PCL micelles were taken up into the ARPE-19 cells by an energy-dependent clatharin and caveolae-mediated endocytosis. Our results indicated that cellular uptake and the anti-proliferation effect of drugloaded micelles were linearly correlated. Drug loading appears to be a critical parameter for cellular uptake which in turn impacts the in vitro bioactivities of polymeric micelles. Our results clearly demonstrated that dasatinib-encapsulated micelles offer considerable promise in the management of PVR.
Figure optionsDownload as PowerPoint slide
Journal: Colloids and Surfaces B: Biointerfaces - Volume 140, 1 April 2016, Pages 278–286